Investor from Japan will start in RT production medical products for ₽2,5 billion

The Japanese company Mirai Genomics will start in Republic of Tatarstan production the device of fast genetic diagnostics of infectious diseases of LifeRing. The volume of investments in the project is estimated at 2,5 billion rubles. It is expected that release of the device of companies Mirai Genomics will reduce infections mortality in the republic...